Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT00058396 · COMPLETED
Trial details
- NCT number
- NCT00058396
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Primary completion
- 2004-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.